Skip to content

Clinical trials

Phase 2 trials in Luxembourg

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Country / region: Luxembourg Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20031
20062
20101
20111
20121
20131
20141
20171
20213
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status3
Terminated2
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cliniques universitaires Saint-Luc- Université Catholique de Louvain3
GERCOR - Multidisciplinary Oncology Cooperative Group3
American University of Beirut Medical Center1
BioTech Tools S.A.1
Bristol-Myers Squibb1
Centre Francois Baclesse, Luxembourg1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
Janssen-Cilag International NV1
SynAgile Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms3
Parkinson Disease3
Breast Neoplasms2
Neoplasm Metastasis2
Bile Duct Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Squamous Cell1
Carcinoma, Transitional Cell1
Cholangiocarcinoma1
Hypersensitivity1

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.